Alloplex Biotherapeutics
PrivateLast Round
Series A
Feb 1, 2023
Total Funding Raised
$16M
Company Overview
Alloplex Biotherapeutics operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Series A round in February 2023.
Alloplex Biotherapeutics is a biotechnology company that develops autologous, non-engineered cellular therapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alloplex Biotherapeutics Comparables
Compare Alloplex Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Marker Therapeutics Inc | 74% | |
| Acepodia | 74% | |
| Iovance Biotherapeutics | 69% |
For institutional investors. Book with your work email.
Alloplex Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 1, 2023 | ||||
| Corporate Funding | Dec 15, 2021 | ||||
| Corporate Funding | Aug 19, 2021 | ||||
| Angel | Jul 24, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alloplex Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Wells Investment | Series A |
| Keiretsu Forum | Series A |
| Hackensack Meridian Health | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
$15M round led by The Wells Investment
- Aug 19, 2021
$1M raised from Daewoong Pharmaceutical and Hanall Biopharma.
For institutional investors. Book with your work email.
Alloplex Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alloplex Biotherapeutics's valuation, stock price, and market status.
Is Alloplex Biotherapeutics a public or private company?
Alloplex Biotherapeutics is a private company.
What is the current stock price of Alloplex Biotherapeutics?
Alloplex Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Alloplex Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alloplex Biotherapeutics worth (valuation)?
Valuation information for Alloplex Biotherapeutics is not publicly available.
Can I buy Alloplex Biotherapeutics stock?
Alloplex Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alloplex Biotherapeutics's last funding round?
Alloplex Biotherapeutics's most recent funding round was Series A on February 1, 2023.
Who are the main investors in Alloplex Biotherapeutics?
Key investors in Alloplex Biotherapeutics include Hackensack Meridian Health.
Will Alloplex Biotherapeutics IPO soon?
No public IPO plans have been announced for Alloplex Biotherapeutics.
How can I track Alloplex Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Alloplex Biotherapeutics's shares on secondary markets.